Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all ...

Another Bay Area company has announced significant job cuts ahead of the holidays. Genetic testing firm 23andMe announced on ...

We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki. The ...

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...

The problems at 23andMe are reflected in the turmoil in its leadership. The board resigned in the summer and only the CEO and ...

On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...

An announcement from 23andMe Holding ( (ME) ) is now available. 23andMe Holding Co. has expanded its Board of Directors by appointing Andre ...